Click for best price
Genomics In Cancer Care Market Size, Share 2024
| Market size in 2023 |
US$ 26050 million
|
Forecast Market size by 2030 |
US$ 69720 million
|
| Growth Rate |
CAGR of 15.0% |
Number of Pages |
128 Pages |
This research report provides a comprehensive analysis of the Genomics In Cancer Care market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Genomics In Cancer Care market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Genomics In Cancer Care, challenges faced by the industry, and potential opportunities for market players.
The global Genomics In Cancer Care market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Genomics In Cancer Care market presents opportunities for various stakeholders, including Diagnostics, Personalized Medicine. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Genomics In Cancer Care market. Additionally, the growing consumer demand present avenues for market expansion.
The global Genomics In Cancer Care market was valued at US$ 26050 million in 2023 and is projected to reach US$ 69720 million by 2030, at a CAGR of 15.0% during the forecast period.
Key Features:
The research report on the Genomics In Cancer Care market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Genomics In Cancer Care market.
Market Overview: The report provides a comprehensive overview of the Genomics In Cancer Care market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Instruments, Consumables), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Genomics In Cancer Care market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Genomics In Cancer Care market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Genomics In Cancer Care market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Genomics In Cancer Care market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Genomics In Cancer Care market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Genomics In Cancer Care market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Genomics In Cancer Care, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Genomics In Cancer Care market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Genomics In Cancer Care market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Instruments
Consumables
Services
Market segment by Application
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research
Global Genomics In Cancer Care Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Illumina
Thermo Fisher scientific
Agilent
Roche
Cancer Genetics
Beckman Coulter
Bio-Rad
Danaher
Sigma Aldrich
Pacific Biosciences
Quest Diagnostics
Luminex
Oxford Gene Technology
PerkinElmer
Qiagen
GE Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genomics In Cancer Care, market overview.
Chapter 2: Global Genomics In Cancer Care market size in revenue.
Chapter 3: Detailed analysis of Genomics In Cancer Care company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genomics In Cancer Care in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Genomics In Cancer Care Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 26050 million
|
| Forecast Market size by 2030 |
US$ 69720 million
|
| Growth Rate |
CAGR of 15.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genomics In Cancer Care Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomics In Cancer Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomics In Cancer Care Overall Market Size
2.1 Global Genomics In Cancer Care Market Size: 2023 VS 2030
2.2 Global Genomics In Cancer Care Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genomics In Cancer Care Players in Global Market
3.2 Top Global Genomics In Cancer Care Companies Ranked by Revenue
3.3 Global Genomics In Cancer Care Revenue by Companies
3.4 Top 3 and Top 5 Genomics In Cancer Care Companies in Global Market, by Revenue in 2023
3.5 Global Companies Genomics In Cancer Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomics In Cancer Care Players in Global Market
3.6.1 List of Global Tier 1 Genomics In Cancer Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Genomics In Cancer Care Market Size Markets, 2023 & 2030
4.1.2 Instruments
4.1.3 Consumables
4.1.4 Services
4.2 By Type - Global Genomics In Cancer Care Revenue & Forecasts
4.2.1 By Type - Global Genomics In Cancer Care Revenue, 2019-2024
4.2.2 By Type - Global Genomics In Cancer Care Revenue, 2025-2030
4.2.3 By Type - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genomics In Cancer Care Market Size, 2023 & 2030
5.1.2 Diagnostics
5.1.3 Personalized Medicine
5.1.4 Drug Discovery
5.1.5 Development
5.1.6 Research
5.2 By Application - Global Genomics In Cancer Care Revenue & Forecasts
5.2.1 By Application - Global Genomics In Cancer Care Revenue, 2019-2024
5.2.2 By Application - Global Genomics In Cancer Care Revenue, 2025-2030
5.2.3 By Application - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Genomics In Cancer Care Market Size, 2023 & 2030
6.2 By Region - Global Genomics In Cancer Care Revenue & Forecasts
6.2.1 By Region - Global Genomics In Cancer Care Revenue, 2019-2024
6.2.2 By Region - Global Genomics In Cancer Care Revenue, 2025-2030
6.2.3 By Region - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Genomics In Cancer Care Revenue, 2019-2030
6.3.2 US Genomics In Cancer Care Market Size, 2019-2030
6.3.3 Canada Genomics In Cancer Care Market Size, 2019-2030
6.3.4 Mexico Genomics In Cancer Care Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Genomics In Cancer Care Revenue, 2019-2030
6.4.2 Germany Genomics In Cancer Care Market Size, 2019-2030
6.4.3 France Genomics In Cancer Care Market Size, 2019-2030
6.4.4 U.K. Genomics In Cancer Care Market Size, 2019-2030
6.4.5 Italy Genomics In Cancer Care Market Size, 2019-2030
6.4.6 Russia Genomics In Cancer Care Market Size, 2019-2030
6.4.7 Nordic Countries Genomics In Cancer Care Market Size, 2019-2030
6.4.8 Benelux Genomics In Cancer Care Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Genomics In Cancer Care Revenue, 2019-2030
6.5.2 China Genomics In Cancer Care Market Size, 2019-2030
6.5.3 Japan Genomics In Cancer Care Market Size, 2019-2030
6.5.4 South Korea Genomics In Cancer Care Market Size, 2019-2030
6.5.5 Southeast Asia Genomics In Cancer Care Market Size, 2019-2030
6.5.6 India Genomics In Cancer Care Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Genomics In Cancer Care Revenue, 2019-2030
6.6.2 Brazil Genomics In Cancer Care Market Size, 2019-2030
6.6.3 Argentina Genomics In Cancer Care Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genomics In Cancer Care Revenue, 2019-2030
6.7.2 Turkey Genomics In Cancer Care Market Size, 2019-2030
6.7.3 Israel Genomics In Cancer Care Market Size, 2019-2030
6.7.4 Saudi Arabia Genomics In Cancer Care Market Size, 2019-2030
6.7.5 UAE Genomics In Cancer Care Market Size, 2019-2030
7 Genomics In Cancer Care Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Genomics In Cancer Care Major Product Offerings
7.1.4 Illumina Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.1.5 Illumina Key News & Latest Developments
7.2 Thermo Fisher scientific
7.2.1 Thermo Fisher scientific Company Summary
7.2.2 Thermo Fisher scientific Business Overview
7.2.3 Thermo Fisher scientific Genomics In Cancer Care Major Product Offerings
7.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.2.5 Thermo Fisher scientific Key News & Latest Developments
7.3 Agilent
7.3.1 Agilent Company Summary
7.3.2 Agilent Business Overview
7.3.3 Agilent Genomics In Cancer Care Major Product Offerings
7.3.4 Agilent Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.3.5 Agilent Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Genomics In Cancer Care Major Product Offerings
7.4.4 Roche Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 Cancer Genetics
7.5.1 Cancer Genetics Company Summary
7.5.2 Cancer Genetics Business Overview
7.5.3 Cancer Genetics Genomics In Cancer Care Major Product Offerings
7.5.4 Cancer Genetics Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.5.5 Cancer Genetics Key News & Latest Developments
7.6 Beckman Coulter
7.6.1 Beckman Coulter Company Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Genomics In Cancer Care Major Product Offerings
7.6.4 Beckman Coulter Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.6.5 Beckman Coulter Key News & Latest Developments
7.7 Bio-Rad
7.7.1 Bio-Rad Company Summary
7.7.2 Bio-Rad Business Overview
7.7.3 Bio-Rad Genomics In Cancer Care Major Product Offerings
7.7.4 Bio-Rad Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.7.5 Bio-Rad Key News & Latest Developments
7.8 Danaher
7.8.1 Danaher Company Summary
7.8.2 Danaher Business Overview
7.8.3 Danaher Genomics In Cancer Care Major Product Offerings
7.8.4 Danaher Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.8.5 Danaher Key News & Latest Developments
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Company Summary
7.9.2 Sigma Aldrich Business Overview
7.9.3 Sigma Aldrich Genomics In Cancer Care Major Product Offerings
7.9.4 Sigma Aldrich Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.9.5 Sigma Aldrich Key News & Latest Developments
7.10 Pacific Biosciences
7.10.1 Pacific Biosciences Company Summary
7.10.2 Pacific Biosciences Business Overview
7.10.3 Pacific Biosciences Genomics In Cancer Care Major Product Offerings
7.10.4 Pacific Biosciences Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.10.5 Pacific Biosciences Key News & Latest Developments
7.11 Quest Diagnostics
7.11.1 Quest Diagnostics Company Summary
7.11.2 Quest Diagnostics Business Overview
7.11.3 Quest Diagnostics Genomics In Cancer Care Major Product Offerings
7.11.4 Quest Diagnostics Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.11.5 Quest Diagnostics Key News & Latest Developments
7.12 Luminex
7.12.1 Luminex Company Summary
7.12.2 Luminex Business Overview
7.12.3 Luminex Genomics In Cancer Care Major Product Offerings
7.12.4 Luminex Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.12.5 Luminex Key News & Latest Developments
7.13 Oxford Gene Technology
7.13.1 Oxford Gene Technology Company Summary
7.13.2 Oxford Gene Technology Business Overview
7.13.3 Oxford Gene Technology Genomics In Cancer Care Major Product Offerings
7.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.13.5 Oxford Gene Technology Key News & Latest Developments
7.14 PerkinElmer
7.14.1 PerkinElmer Company Summary
7.14.2 PerkinElmer Business Overview
7.14.3 PerkinElmer Genomics In Cancer Care Major Product Offerings
7.14.4 PerkinElmer Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.14.5 PerkinElmer Key News & Latest Developments
7.15 Qiagen
7.15.1 Qiagen Company Summary
7.15.2 Qiagen Business Overview
7.15.3 Qiagen Genomics In Cancer Care Major Product Offerings
7.15.4 Qiagen Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.15.5 Qiagen Key News & Latest Developments
7.16 GE Healthcare
7.16.1 GE Healthcare Company Summary
7.16.2 GE Healthcare Business Overview
7.16.3 GE Healthcare Genomics In Cancer Care Major Product Offerings
7.16.4 GE Healthcare Genomics In Cancer Care Revenue in Global Market (2019-2024)
7.16.5 GE Healthcare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genomics In Cancer Care Market Opportunities & Trends in Global Market
Table 2. Genomics In Cancer Care Market Drivers in Global Market
Table 3. Genomics In Cancer Care Market Restraints in Global Market
Table 4. Key Players of Genomics In Cancer Care in Global Market
Table 5. Top Genomics In Cancer Care Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Genomics In Cancer Care Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Genomics In Cancer Care Revenue Share by Companies, 2019-2024
Table 8. Global Companies Genomics In Cancer Care Product Type
Table 9. List of Global Tier 1 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Genomics In Cancer Care Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Genomics In Cancer Care Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Genomics In Cancer Care Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2025-2030
Table 30. Illumina Company Summary
Table 31. Illumina Genomics In Cancer Care Product Offerings
Table 32. Illumina Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 33. Illumina Key News & Latest Developments
Table 34. Thermo Fisher scientific Company Summary
Table 35. Thermo Fisher scientific Genomics In Cancer Care Product Offerings
Table 36. Thermo Fisher scientific Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 37. Thermo Fisher scientific Key News & Latest Developments
Table 38. Agilent Company Summary
Table 39. Agilent Genomics In Cancer Care Product Offerings
Table 40. Agilent Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 41. Agilent Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Genomics In Cancer Care Product Offerings
Table 44. Roche Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 45. Roche Key News & Latest Developments
Table 46. Cancer Genetics Company Summary
Table 47. Cancer Genetics Genomics In Cancer Care Product Offerings
Table 48. Cancer Genetics Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 49. Cancer Genetics Key News & Latest Developments
Table 50. Beckman Coulter Company Summary
Table 51. Beckman Coulter Genomics In Cancer Care Product Offerings
Table 52. Beckman Coulter Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 53. Beckman Coulter Key News & Latest Developments
Table 54. Bio-Rad Company Summary
Table 55. Bio-Rad Genomics In Cancer Care Product Offerings
Table 56. Bio-Rad Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 57. Bio-Rad Key News & Latest Developments
Table 58. Danaher Company Summary
Table 59. Danaher Genomics In Cancer Care Product Offerings
Table 60. Danaher Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 61. Danaher Key News & Latest Developments
Table 62. Sigma Aldrich Company Summary
Table 63. Sigma Aldrich Genomics In Cancer Care Product Offerings
Table 64. Sigma Aldrich Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 65. Sigma Aldrich Key News & Latest Developments
Table 66. Pacific Biosciences Company Summary
Table 67. Pacific Biosciences Genomics In Cancer Care Product Offerings
Table 68. Pacific Biosciences Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 69. Pacific Biosciences Key News & Latest Developments
Table 70. Quest Diagnostics Company Summary
Table 71. Quest Diagnostics Genomics In Cancer Care Product Offerings
Table 72. Quest Diagnostics Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 73. Quest Diagnostics Key News & Latest Developments
Table 74. Luminex Company Summary
Table 75. Luminex Genomics In Cancer Care Product Offerings
Table 76. Luminex Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 77. Luminex Key News & Latest Developments
Table 78. Oxford Gene Technology Company Summary
Table 79. Oxford Gene Technology Genomics In Cancer Care Product Offerings
Table 80. Oxford Gene Technology Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 81. Oxford Gene Technology Key News & Latest Developments
Table 82. PerkinElmer Company Summary
Table 83. PerkinElmer Genomics In Cancer Care Product Offerings
Table 84. PerkinElmer Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 85. PerkinElmer Key News & Latest Developments
Table 86. Qiagen Company Summary
Table 87. Qiagen Genomics In Cancer Care Product Offerings
Table 88. Qiagen Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 89. Qiagen Key News & Latest Developments
Table 90. GE Healthcare Company Summary
Table 91. GE Healthcare Genomics In Cancer Care Product Offerings
Table 92. GE Healthcare Genomics In Cancer Care Revenue (US$, Mn) & (2019-2024)
Table 93. GE Healthcare Key News & Latest Developments
List of Figures
Figure 1. Genomics In Cancer Care Segment by Type in 2023
Figure 2. Genomics In Cancer Care Segment by Application in 2023
Figure 3. Global Genomics In Cancer Care Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Genomics In Cancer Care Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Genomics In Cancer Care Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2023
Figure 8. By Type - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 9. By Application - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 10. By Type - Global Genomics In Cancer Care Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 12. By Application - Global Genomics In Cancer Care Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 14. By Region - Global Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 15. By Country - North America Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 16. US Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 20. Germany Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 21. France Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 28. China Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 32. India Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 34. Brazil Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Genomics In Cancer Care Revenue Market Share, 2019-2030
Figure 37. Turkey Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Genomics In Cancer Care Revenue, (US$, Mn), 2019-2030
Figure 41. Illumina Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Thermo Fisher scientific Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Agilent Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Roche Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Cancer Genetics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Beckman Coulter Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bio-Rad Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Danaher Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sigma Aldrich Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Pacific Biosciences Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Quest Diagnostics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Luminex Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Oxford Gene Technology Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. PerkinElmer Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Qiagen Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. GE Healthcare Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
